Two-Thirds of Severe Covid-19 Cases Improved on Gilead Drug
Signage is displayed outside Gilead Sciences headquarters in in Foster City, California, on March 19, 2020. (Photographer: David Paul Morris/Bloomberg)

Two-Thirds of Severe Covid-19 Cases Improved on Gilead Drug

(Bloomberg) --
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.